Research and experimental development on natural sciences and engineering
BIOVIVOTECH AS
Revenue 2024
NOK 2.7m
Operating profit
NOK 594,000
Equity
NOK 1.3m
Incorporated
2009
Share capital
NOK 600,000
Key figures · 2024
Current ratio
2.45
Equity ratio
40.4%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 21.6% | |
| Net margin (%%) | 21.5% | |
| Return on assets (%%) | 18.7% | |
| Likviditet | ||
| Current ratio | 2.45 | |
| Working capital | 1.8m | |
| Soliditet | ||
| Equity ratio (%%) | 40.4% | |
| Debt-to-equity ratio | 1.47 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.